Scientists are discovering that a substance called lithocholic acid (LCA), which is made by bacteria in your gut, might help fight cancer. This review examines how LCA works in the body to stop cancer cells from growing while leaving healthy cells alone. Researchers found that LCA can trigger cancer cells to self-destruct through several different mechanisms, and it may also help your immune system fight tumors. While these findings are exciting and come from laboratory and early studies, scientists are still working to understand exactly how to use this discovery to treat cancer in people. This research suggests that the trillions of bacteria living in our digestive system might be a source of new cancer treatments.
The Quick Take
- What they studied: How a natural substance made by gut bacteria called lithocholic acid (LCA) affects cancer cells and whether it could be used as a cancer treatment
- Who participated: This is a review article that summarizes findings from many different laboratory and animal studies—not a single study with human participants
- Key finding: Lithocholic acid appears to kill cancer cells in breast, prostate, colon, and brain tumors by triggering them to self-destruct, while seemingly leaving normal cells unharmed
- What it means for you: This research is still in early stages and hasn’t been tested in humans yet, but it suggests that future cancer treatments might come from understanding our gut bacteria better. Don’t expect this to be available as a treatment soon, but it’s an encouraging direction for cancer research
The Research Details
This is a review article, meaning the authors read and summarized many different scientific studies about lithocholic acid and cancer. They looked at laboratory experiments where scientists tested LCA on cancer cells in dishes and in animals, examining how the substance works at the molecular level. The researchers organized their findings to explain the different ways LCA appears to fight cancer and discussed what this means for developing new treatments. This type of article doesn’t involve testing on humans but instead pulls together what scientists have already discovered to identify patterns and possibilities.
Review articles are important because they help scientists and doctors see the big picture. By combining results from many different studies, researchers can identify which findings are most reliable and which areas need more investigation. This particular review is valuable because it shows that lithocholic acid has multiple ways of fighting cancer, which makes it a more promising candidate for future drug development than substances that work in only one way.
This review was published in a scientific journal called Experimental Cell Research, which means it went through peer review by other experts. However, because this is a review of laboratory and animal studies rather than human trials, the findings are still preliminary. The research is based on solid science, but much more testing would be needed before this could become a treatment for people. Readers should understand that promising laboratory results don’t always translate to effective human treatments.
What the Results Show
Lithocholic acid appears to kill cancer cells through multiple mechanisms. First, it can trigger cancer cells to undergo apoptosis, which is essentially programmed cell death—the cell essentially self-destructs. This process involves both internal pathways (intrinsic) and external signals (extrinsic) within the cancer cell. Second, LCA causes stress in the endoplasmic reticulum, which is a structure inside cells that helps make proteins, and this stress contributes to cancer cell death. Third, the substance can interfere with mitochondria, the energy-producing structures in cells, which weakens cancer cells. Finally, LCA creates oxidative stress—essentially damaging molecules—inside cancer cells, which also contributes to their death. What makes these findings particularly exciting is that in laboratory studies, LCA appears to selectively target cancer cells while leaving normal, healthy cells relatively unharmed.
Beyond directly killing cancer cells, lithocholic acid appears to have additional anti-cancer effects. It may help regulate the tumor microenvironment—the tissue and cells surrounding a tumor—by modulating the immune system and reducing inflammation. This means LCA might help your body’s natural defenses recognize and attack cancer cells more effectively. The substance also appears to work through specific receptors on cells, including the vitamin D receptor, which suggests it could be developed into targeted therapies. Additionally, LCA may inhibit proteasome activity, which is important because cancer cells often depend on proteasomes to survive.
Interestingly, previous research had suggested that lithocholic acid might actually promote cancer, which is why this review is particularly important. By examining more recent studies, the authors show that LCA’s effect on cancer depends on the specific type of cancer and the molecular environment. This demonstrates that the relationship between LCA and cancer is more nuanced than initially thought. The finding that LCA can act as a tumor suppressor in multiple cancer types (breast, prostate, colon, and neuroblastoma) represents a shift in scientific understanding and opens new research directions.
This review has several important limitations. First, all the studies reviewed were conducted in laboratories or in animals—no human trials have been completed yet. Laboratory results often don’t translate directly to human treatments due to differences in how bodies process substances and respond to them. Second, the review doesn’t include information about how much LCA would need to be given to a person or whether it could be safely delivered to cancer cells in the human body. Third, we don’t yet know about potential side effects in humans or how LCA might interact with other medications. Finally, because LCA is a natural product made by bacteria, the amount and type produced varies between individuals, which could affect how well a treatment based on it would work for different people.
The Bottom Line
Based on current evidence, lithocholic acid cannot yet be recommended as a cancer treatment for people. The research is promising but remains in early laboratory stages. If you or a loved one is dealing with cancer, continue working with your oncologist on proven treatments. However, this research suggests that future cancer treatments may come from studying gut bacteria, so staying informed about microbiome research is worthwhile. Confidence level: Low for human application; Moderate for future research potential.
Cancer researchers and pharmaceutical companies should pay close attention to this work, as it identifies a promising new direction for drug development. People interested in preventive health and gut health might find this research interesting as it highlights the importance of a healthy microbiome. However, people currently being treated for cancer should not attempt to use lithocholic acid or change their treatment based on this review. Anyone with a family history of cancer might want to follow developments in microbiome-based cancer research.
If lithocholic acid does eventually become a cancer treatment, it would likely take 10-15 years of additional research, animal testing, and human clinical trials before it could be approved and available to patients. The path from laboratory discovery to approved medication is long and requires extensive safety and effectiveness testing.
Want to Apply This Research?
- Users interested in gut health could track daily probiotic intake, fiber consumption, and digestive symptoms to monitor their microbiome health. This could include logging servings of fermented foods, prebiotic foods, and overall digestive comfort on a 1-10 scale.
- Users could implement dietary changes to support a healthy gut microbiome, such as increasing fiber intake through whole grains and vegetables, consuming fermented foods like yogurt or sauerkraut, and reducing processed foods. These changes support the bacteria that produce beneficial metabolites like lithocholic acid.
- Create a long-term wellness tracking system that monitors gut health indicators (digestive comfort, energy levels, immune function markers if available) alongside lifestyle factors. Users could set monthly goals for probiotic-rich foods and fiber intake, with reminders to maintain consistency and track patterns over 3-6 month periods.
This article summarizes early-stage laboratory research and should not be used to diagnose, treat, or prevent cancer. Lithocholic acid is not currently approved as a cancer treatment for humans. If you have been diagnosed with cancer or have concerns about cancer risk, please consult with a qualified oncologist or healthcare provider about proven treatment options. Do not stop, change, or replace any current cancer treatment based on this information. This review discusses promising research directions, but much more testing is needed before any new treatments could become available to patients.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.